From biomarker to market: Optimizing access for precision therapies

Accelerate market access for precision therapies with practical strategies in this expert webinar.

Precision medicine is reshaping oncology, neurology, rare disease, and cell and gene therapy drug development. Yet many therapies face significant hurdles to market access, reimbursement and adoption due to limited evidence, small patient populations, evolving endpoints and increasing payer scrutiny.

Watch this expert webinar to learn how leading health care organizations are using real-world data and integrated evidence strategies to support market access, reimbursement and commercial success.

Explore how leading developers secure access for precision therapies

Gain practical insights on how to:

Navigate policy changes and evolving payer expectations for access and reimbursement

Address evidence gaps in biomarker-defined populations

Demonstrate value using real-world data and external comparators

Incorporate patient-centered evidence to enhance differentiation

Create evidence packages that support both approval and payer decision-making

Access the webinar recording to gain a practical market access framework for transforming precision therapies from promising science into payer-recognized value.

Access the webinar to gain practical insights